Rotator Cuff Treatment Market Size (2024 - 2029)

The rotator cuff treatment market is projected to experience growth due to several key factors, including an increase in sports-related injuries and advancements in treatment technologies. The rising incidence of shoulder and rotator cuff injuries, particularly among athletes, is expected to drive demand for treatment products. Technological innovations and regulatory approvals for new devices are anticipated to enhance treatment effectiveness and accessibility, further contributing to market expansion. Despite these positive trends, the high cost of treatment may pose a challenge to market growth.

Market Size of Rotator Cuff Treatment Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Rotator Cuff Treatment Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 532.94 Million
Market Size (2029) USD 676.95 Million
CAGR (2024 - 2029) 4.90 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Rotator Cuff Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Rotator Cuff Treatment Market Analysis

The Rotator Cuff Treatment Market size is estimated at USD 532.94 million in 2024, and is expected to reach USD 676.95 million by 2029, growing at a CAGR of 4.90% during the forecast period (2024-2029).

The major factors driving the growth of the market are the rising number of sports-related injuries and technological advancements in rotator cuff rupture devices, as well as growing public-private funding grants and educational awareness initiatives. For instance, as per the Australian Institutes of Health and Welfare, in March 2023, 52,300 sports-related injuries in Australia resulted in hospital stays yearly. Arm or shoulder fractures were the most frequent (representing 41% of all fractures, or 10,800 cases). Thus, the growing burden of shoulder and sports injuries will increase the demand for rotator cuff treatment products during the forecast period.

Further, the rotator cuff is a common shoulder injury in athletes. The increasing burden of rotator cuff is expected to contribute to market growth during the forecast period. For instance, according to the article published by the American Academy of Orthopaedic Surgeons (AAOS) in August 2022, almost 2 million people in the United States visit a healthcare provider with issues related to their rotator cuff every year. Thus, the market is expected to gain traction due to the global increase in shoulder and rotator cuff injuries.

The advancement in rotator cuff rupture devices and regulatory approval may increase their effectiveness, likely boosting market growth. For instance, in July 2023, iSmith+Nephew announced the launch of its REGENETEN Bioinductive Implant in India. With more than 100,000 procedures completed globally since its introduction, the REGENETEN implant has significantly impacted how surgeons approach rotator cuff procedures. Thus, the launch of such implants for treating rotator cuff injuries is expected to increase access to patients and physicians during the forecast period.

Additionally, in May 2022, Embody Inc. stated that the Food and Drug Administration (FDA) granted 510(k) clearance for its TAPESTRY RC System to treat rotator cuff dysfunction. The TAPESTRY RC System, which is specifically created for arthroscopic surgeries, combines the healing benefits of the bio-integrative collagen TAPESTRY implant with simplified distribution and bioabsorbable anchor anchoring. As the number of new products receiving FDA approval and hitting the market increases, this trend is expected to impact the industry's growth over the forecast period positively.

Thus, all the aforementioned factors, such as the growing burden of shoulder injuries, technological advancements, and rising approval by the FDA, are expected to boost the market growth. However, the high cost associated with the treatment is expected to hinder market growth during the forecast period.

Rotator Cuff Treatment Industry Segmentation

As per the scope of the report, the rotator cuff comprises muscles and tendons that keep the ball (head) of the upper arm bone (humerus) in the shoulder socket. The common rotator cuff injuries are rotator cuff tears, tendinitis, bursitis, and degenerative injuries. The rotator cuff treatment market is segmented by type, injury severity, and geography. The market is segmented by type into surgical or curative treatment, physiotherapy or palliative treatment, pharmaceutical drugs or preventive treatment, and orthobiologics. By injury severity, the market is segmented into full-thickness and partial-thickness. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Type
Surgical treatment or curative treatment
Physiotherapy or Palliative treatment
Pharmaceutical drugs or preventive treatment
Orthobiologics
By Injury Severity
Full-Thickness
Partial-Thickness
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Rotator Cuff Treatment Market Size Summary

The rotator cuff treatment market is poised for significant growth, driven by an increasing incidence of sports-related injuries and advancements in treatment technologies. The market is expected to expand steadily over the forecast period, supported by rising public and private funding, as well as educational initiatives aimed at raising awareness about rotator cuff injuries. The prevalence of shoulder injuries, particularly among athletes, is a key factor contributing to market demand. Technological innovations, such as the introduction of bioinductive implants and FDA-approved systems for arthroscopic surgeries, are enhancing treatment efficacy and accessibility, further propelling market growth. Despite the high costs associated with these treatments, the benefits of advanced surgical procedures, including reduced complications and faster recovery times, are expected to drive the market forward.

North America is anticipated to lead the rotator cuff treatment market, bolstered by ongoing research, favorable insurance policies, and a significant sports participation rate. The aging population in the region, coupled with the increasing prevalence of chronic orthopedic conditions, is also contributing to market expansion. Strategic activities by key market players, such as product launches and collaborations, are strengthening their market positions and fostering innovation. The market remains consolidated, with a few major companies dominating the landscape. As research and development activities continue to advance, the market is expected to experience sustained growth, driven by the need for effective rotator cuff injury treatments and the introduction of novel therapeutic solutions.

Explore More

Rotator Cuff Treatment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Number of Sports-Related Shoulder Injuries

      2. 1.2.2 Rising Technological Advancements in Rotator Cuff Rupture Devices

      3. 1.2.3 Growing Public-Private Funding Grants and Educational Awareness Initiatives

    3. 1.3 Market Restraints

      1. 1.3.1 High Costs Associated with Arthroscopic Surgery Instruments

      2. 1.3.2 Shortage of Trained Orthopedic Professionals

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Type

      1. 2.1.1 Surgical treatment or curative treatment

      2. 2.1.2 Physiotherapy or Palliative treatment

      3. 2.1.3 Pharmaceutical drugs or preventive treatment

      4. 2.1.4 Orthobiologics

    2. 2.2 By Injury Severity

      1. 2.2.1 Full-Thickness

      2. 2.2.2 Partial-Thickness

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Rotator Cuff Treatment Market Size FAQs

The Rotator Cuff Treatment Market size is expected to reach USD 532.94 million in 2024 and grow at a CAGR of 4.90% to reach USD 676.95 million by 2029.

In 2024, the Rotator Cuff Treatment Market size is expected to reach USD 532.94 million.

Rotator Cuff Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)